and Joanne Harack vice president, human resources and corporate communications...Aton Pharma Inc., of Tarrytown, N.Y., appointed Carolyn Paradise senior vice president and chief medical officer

A.P. Pharma Inc., of Redwood City, Calif., appointed Robert Zerbe to its board...ISTA Pharmaceuticals Inc., of Irvine, Calif., appointed Kathleen LaPorte, Liza Nelson and Peter Hutt to its board

Aton Pharma Inc., of Tarrytown, N.Y., formed a scientific advisory board consisting of Paul Marks as chairman, Joseph Bertino, Ronald Breslow, Samuel Danishefsky, Joseph Goldstein, Richard Rifkind and Daniel Von Hoff

Aton Pharma Inc., of Tarrytown, N.Y., promoted Judy Chiao to vice president, oncology clinical research and development

PhageTech Inc., of Montreal, appointed Jinzi Jason vice president, research and development...ProdiGene Inc., of College Station, Texas, said its CEO and president, Anthony Laos, was appointed by President George W. Bush to serve as a member of the Board for International Food and Agriculture Development

Ixion Biotechnology Inc., of Alachua, Fla., added Albert Fosmoe as senior manager, regulatory affairs and quality assurance, and Chris Setina and Marlo Tan Walpole to its oxalate control product program...MGI Pharma Inc., of Minneapolis, appointed Edward Mehrer to its board

Corus Pharma Inc., of Seattle, named William Baker vice president of research...CytoGenix Inc., of Houston, elected Scott Parazynski and Frank Vazquez to its board

and Lioudmila Tchistiakova as section head, microbiology and genomics...and named John Prunty treasurer and assistant corporate secretary

Biophage Pharma Inc., of Montreal, appointed Toney Ilenchuk vice president and chief development officer

Corus Pharma Inc., of Seattle, named Kirby Cramer to its board...Innate Pharma SAS, of Marseille, France, appointed Philippe Pouletty and Bernard Malissen to its board

Miza Pharmaceuticals Inc., of Toronto, appointed Michael Kirby and Geoffrey Shulman to its board...Supratek Pharma Inc., of Montreal, appointed John Hooper to its board

PanGeo Pharma Inc., of Montreal, appointed Daniel Pharand executive vice president, business development...Targeted Genetics Corp., of Seattle, appointed Todd Simpson vice president, finance and administration, and chief financial officer

Select Therapeutics Inc., of Woburn, Mass., and its privately held joint venture, Cell Science Therapeutics Inc., formed a medical and scientific advisory board...SYN X Pharma Inc., of Toronto, appointed Rod Wilson chief operating officer

AltaRex Corp., of Waltham, Mass., appointed Bruce Brydon and Jacques Lapointe to its board...AP Pharma Inc., of Redwood City, Calif., appointed Jayne Lange vice president, business development

MGI Pharma Inc., of Minneapolis, elected Philip Schein and David Sharrock to its board

Ladenburg Thalmann, of New York, added Albert Rauch and Edward Nash as senior health care equity research analysts...SYN X Pharma Inc., of Toronto, added Allison Manners as director, regulatory affairs

SYN X Pharma Inc., of Toronto, added Aaron Davidson as vice president, business development...Limber is president and CEO of Aclara BioSciences Inc., of Mountain View, Calif

Advanced Pharma Inc., of Gaithersburg, Md., appointed Gordon Douglas and Wayne Hockmeyer to its board...and Premchandran Ramiya director of process research and development

RxKinetix Inc., of Louisville, Colo., named Kenneth Lynn senior vice president of corporate development and legal affairs...SYN X Pharma Inc., of Toronto, appointed Bradley Thatcher vice president, proteomics discovery